Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and ciprofol mixture ratio evaluation for hysteroscopic surgery
ChiCTR2500096597Phase 4Not yet recruiting
- Sponsor
- Dalian Municipal Central Hospital
- Start
- Jan 2025
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine and ciprofol (3 arms), sponsored by Dalian Municipal Central Hospital. Primary endpoints: Incidence of respiratory depression and Sedation score. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
esketamineciprofol
Beyond the preview
Go deeper on ChiCTR2500096597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500096597.